X. Huang et al. / Tetrahedron Letters 49 (2008) 3592–3595
3593
OMe
This is a surprising but satisfactory result. We hypothesized
that the enrichment of the stereoselectivity might be an
equilibration process involving a six-membered intermedi-
ate (Scheme 3). After initial palladium mediated proton
transfer between 6 and acetamide to form intermediate
6a, 6a can isomerize to palladium chelated intermediate
6b (pathway A). Upon protonation, the favored intermedi-
ate 6c will prevail and further transform to the desired
major product 7. To this point, side chain 7 was prepared
in an overall 36% yield in 7 steps with good diastereoselec-
tivity. An alternative mechanistic pathway (Scheme 3,
pathway B) is also possible. This involves the initial con-
version of 6a to ketenimine 6e. Subsequent hydration of
6e followed by diastereoselective protonation would lead
to the major product 7.
OMe
H
a-b
c-d
O
OTBS
O
OTBS
4
3
5
e-f
OMe O
OMe
g
CN
OTPS
NH2
OTPS
6
7
Scheme 2. Synthesis of the acyclic ‘psymberate’ side chain. Reagents and
conditions: (a) 2-propenylMgBr, CuI, THF, ꢁ15 °C, 90%; (b) Me3OBF4,
proton sponge, CH2Cl2, 95%; (c) TBAF, THF, 90%; (d) DMP, CH2Cl2,
0 °C to rt, 80%; (e) (1) TMSCN, K2CO3, Et2O, 0 °C, rt, 91%; (2) TBAF,
THF, 95% dr = 1:1; (f) TPSCl, NEt3, DMAP, CH2Cl2, 95%; (g)
MeCONH2, PdCl2, H2O, THF, 71% (pure isomer).
With amide 7 in hand, we proceeded to complete the
synthesis (Scheme 4). Vinyl iodide 83 was coupled with
compound 7 using CuI7 under Buchwald conditions to give
protected N-acyl enamine 9, and the major product E-iso-
mer was separated at this stage. Upon treatment of E-9
with NaOMe/MeOH followed with TBAF at 50 °C, a glo-
bal deprotection was realized to give seco-psymberin 2.
With 2 in hand, we studied its antiproliferation activity in
a human lung cancer cell line (HOP62), and found that it
was weakly active (IC50 >1 ꢀ 104 nM). This result suggests
that the 2-(N-acylaminal) substituted tetrahydropyran por-
tion of psymberin is crucial for its potent cytotoxic activity.
Since we had compound 9 in hand, we also attempted to
complete the total synthesis of psymberin with this material
(Scheme 5). Cyclization precursor enamide 10 (E/Z = 5/1)
was synthesized from 9 (E/Z = 5/1) in two operations: (1)
removal of C13, C15 acetate, and O21 TIPS groups with
NaOMe/MeOH, (2) acetylation of O21. Surprisingly, when
we subjected compound 10 under the PhI(OAc)2 mediated
cyclization reaction, the reaction was rather complex. After
isolation of the products and careful NMR analysis, we
connect C14–C15. Our synthesis started with the prepara-
tion of unsaturated ‘psymberamide’ side chain 7 (C1–N7).
Although a few research groups have reported the synthesis
of the ‘psymberate’ side chain,5 we decided to employ a
commercially available chiral precursor (3) to set up the
C4 chiral center (Scheme 2).
Regioselective epoxide opening of 3 with isopropenyl-
magnesium bromide gave a secondary alcohol which was
protected as a methyl ether with Me3OBF4 to give 4. Ether
4 was converted to 5 in 2 steps via deprotection of the TBS
group and Dess–Martin oxidation. Aldehyde 5 underwent
basic cyanohydrin formation (dr = 1:1), deprotection of
the TMS group with TBAF, and protection of the free
alcohol as a TPS ether to give nitrile 6. At this point, we
did not attempt to improve the stereoselectivity at C5.
When the nitrile was subjected to hydrolysis under very
mild conditions,6 we successfully obtained amide 7 not only
in good yield but also in good diastereoselectivity (3:1 to
5:1 in favor of the desired product, isomers were easily sep-
arated at this step with silica gel column chromatography).
Pd(II)(H2O)
Pd(II)(H2O)
pathway
B
H
H
OMe N
O
NH
O
N
NH
NH
7 & 7'
O
O
OTPS
OTPS
OTPS
6
6a
6e
pathway A
Pd(II)(H2O)
Pd(II)(H2O)
Pd(II)(H2O)
Pd
O
NH
NH
O
NH
protonation
favored
NH
protonation
unfavored
O
NH
NH
O
OTPS
O
OTPS
O
OTPS
6b
6c
6d
minor product
Pd(II)(H2O)
major product
Pd(II)(H2O)
OMe NH2
OMe NH2
N
N
O
OTPS
O
OTPS
7'
7
Scheme 3. Possible mechanism for the stereochemistry enrichment at C5.